# Smruthi Organic (NSE: SMRUTHIORG) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SMRUTHIORG · Pivot · prices to 19 Oct 2026

With a market capitalisation of ₹135 Cr, it ranks 2495th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - Specialty & Generic.

Its return on equity was 5.0% in FY25. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹29 Cr (−23.6% year on year) and net profit ₹1 Cr (−52.0%), on a standalone basis. Promoters held 64.73% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹135 Cr |
| ROE | 5.0% (FY25) |
| ROCE | 8.4% (FY25) |
| Debt to equity | 0.23 |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹29 Cr | −23.6% | ₹1 Cr | −52.0% | ₹0.93 |
| Q3 FY26 | ₹22 Cr | −28.7% | ₹1 Cr | −5.4% | ₹1.22 |
| Q2 FY26 | ₹32 Cr | +7.5% | ₹2 Cr | +164.1% | ₹1.80 |
| Q1 FY26 | ₹19 Cr | −30.4% | −₹1 Cr | — | −₹0.96 |
| Q4 FY25 | ₹38 Cr | −4.0% | ₹2 Cr | +46.7% | ₹1.95 |
| Q3 FY25 | ₹31 Cr | +33.1% | ₹1 Cr | — | ₹1.29 |
| Q2 FY25 | ₹29 Cr | −0.7% | ₹1 Cr | −62.3% | ₹0.68 |
| Q1 FY25 | ₹27 Cr | −21.9% | −₹1 Cr | −140.2% | −₹0.81 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹126 Cr | ₹4 Cr |
| FY24 | ₹128 Cr | ₹4 Cr |
| FY23 | ₹141 Cr | ₹4 Cr |
| FY22 | ₹133 Cr | ₹10 Cr |
| FY21 | ₹127 Cr | ₹17 Cr |
| FY20 | ₹131 Cr | ₹8 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 64.73%
- Non-institutions: 35.27%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Lactose India](https://app.pivotnow.in/stock/LACTOSE) | — | ₹132 Cr | — | — |
| [Valencia Nutrit](https://app.pivotnow.in/stock/VALENCIA) | — | ₹132 Cr | — | — |
| [Par Drugs And Chemicals](https://app.pivotnow.in/stock/PAR) | ₹105.25 | ₹130 Cr | 9.9 | — |
| [Aspira Pathlab](https://app.pivotnow.in/stock/ASPIRA) | — | ₹125 Cr | — | — |
| [Parnax Lab](https://app.pivotnow.in/stock/PARNAXLAB) | ₹108.95 | ₹125 Cr | 10.6 | — |
| [Krebs Biochemicals and Industries](https://app.pivotnow.in/stock/KREBSBIO) | ₹57.16 | ₹123 Cr | — | — |

## Questions and answers

### What is the market cap of Smruthi Organic?

Smruthi Organic's market capitalisation is ₹135 Cr (₹135 Cr) at the 19 Oct 2026 close, ranking 2495th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Smruthi Organic?

Return on equity was 5.0% in FY25 and return on capital employed was 8.4% in FY25 (standalone figures).

### Is Smruthi Organic a debt-free company?

No. Smruthi Organic's debt-to-equity ratio was 0.23 in FY25, with total debt of ₹8 Cr.

### What were Smruthi Organic's latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Smruthi Organic reported revenue of ₹29 Cr, −23.6% year on year, and net profit of ₹1 Cr, −52.0% year on year.

### What is the shareholding pattern of Smruthi Organic?

As of 30 Jun 2026: promoters 64.73%, non-institutions 35.27%.

### Who are Smruthi Organic's competitors?

The listed Pharma & Healthcare companies closest to Smruthi Organic by market cap are Lactose India, Valencia Nutrit, Par Drugs And Chemicals, Aspira Pathlab, Parnax Lab and Krebs Biochemicals and Industries.

### Is Smruthi Organic a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Smruthi Organic's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SMRUTHIORG against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.